Company filings profile · CIK 0001517681
Propanc Biopharma, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Propanc Biopharma, Inc. (PPCB): 7 filings in the last 90 days vs 5 in the prior 90 (filing-velocity rising ↑ · 1.4×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 6, 2026. Source-linked, daily-refreshed.
Material 8-K events — Propanc Biopharma, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jul 14, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Feb 26, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jan 7, 2026 | Delisting / Listing-Rule Failure | ↗ |
| Nov 10, 2025 | Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Oct 14, 2025 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Aug 19, 2025 | Entry into a Material Agreement; Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
Watch Propanc Biopharma, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
| Filed | Form | |
|---|---|---|
| No insider filings in the current window. | ||
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 5, 2026 | S-1 | S-1 | ↗ |
| Sep 25, 2026 | 10-K | 10-K | ↗ |
| Aug 21, 2026 | DEF 14C | DEF 14C | ↗ |
| Aug 5, 2026 | PRE 14C | PRE 14C | ↗ |
| Jul 27, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 17, 2026 | S-1 | S-1 | ↗ |
| Jul 14, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| Apr 20, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Apr 16, 2026 | CORRESP | ↗ | |
| Apr 15, 2026 | UPLOAD | ↗ | |
| Apr 10, 2026 | S-1 | S-1 | ↗ |
| Mar 31, 2026 | DEF 14C | DEF 14C | ↗ |
| Mar 20, 2026 | PRE 14C | PRE 14C | ↗ |
| Mar 19, 2026 | PRE 14A | PRE 14A | ↗ |
| Mar 6, 2026 | 424B3 | 424B3 | ↗ |
| Feb 26, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Feb 24, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Feb 20, 2026 | CORRESP | ↗ | |
| Feb 19, 2026 | S-1/A | S-1/A | ↗ |
| Feb 17, 2026 | 10-Q | 10-Q | ↗ |
| Feb 12, 2026 | CORRESP | ↗ | |
| Feb 10, 2026 | CORRESP | ↗ | |
| Feb 10, 2026 | UPLOAD | ↗ | |
| Feb 2, 2026 | S-1 | S-1 | ↗ |
| Jan 30, 2026 | 424B3 | 424B3 | ↗ |
| Jan 9, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jan 7, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Jan 6, 2026 | CORRESP | ↗ | |
| Jan 5, 2026 | UPLOAD | ↗ | |
| Dec 30, 2025 | S-1 | S-1 | ↗ |
| Dec 29, 2025 | DEF 14C | DEF 14C | ↗ |
| Dec 10, 2025 | PRE 14C | PRE 14C | ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A | ↗ | |
| Nov 14, 2025 | 10-Q | 10-Q | ↗ |
| Nov 10, 2025 | 8-K | Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Oct 14, 2025 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Sep 29, 2025 | 10-K | 10-K | ↗ |
| Aug 19, 2025 | 8-K | Entry into a Material Agreement; Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 19, 2025 | SCHEDULE 13G | ↗ |